Capital World Investors Ionis Pharmaceuticals Inc Transaction History
Capital World Investors
- $633 Billion
- Q4 2024
A detailed history of Capital World Investors transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Capital World Investors holds 11,465,413 shares of IONS stock, worth $356 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,465,413
Previous 7,828,372
46.46%
Holding current value
$356 Million
Previous $314 Million
27.81%
% of portfolio
0.06%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
841KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$511 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$440 Million0.31% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$320 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$269 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$244 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.41B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...